The first truly multidisciplinary, practical reference for decision-making in soft tissue tumor diagnosis and treatment Soft tissue tumors (STTs) are frequently misdiagnosed in inexperienced hands. Having diagnosed and treated hundreds of patients with these difficult tumors in the last few years, Institut Curie physicians have collected core data that have contributed to breakthrough research in the morphological, biological, and molecular aspects of soft tissue tumors, resulting in valuable translational and clinical applications to patient treatment. Soft Tissue Tumors: A Multidisciplinary, Decisional Diagnostic Approach presents a distillation of these experiences combined with valuable data and perspectives contributed by senior pathologists, oncologists, and radiologists from several other of the world's leading cancer centers of excellence.
Using state-of-the-art laboratory and clinical techniques, this balanced guide carefully considers and combines clinical pathologic (including molecular, cytogenetic, cytological, and histopathologic), radiologic, and medical and surgical oncologic data. Purposely designed to optimize the STT patient's specific disease diagnosis and management, it provides carefully developed insights into the decision-making process and diagnostic and treatment support for a comprehensive array of STTs. Coverage includes:
-
Fully developed cytological and cytopathologic differential diagnosis, with careful consideration of both "large-sample" and "small-sample" diagnostic techniques
-
Practical tumor classification and staging, carefully calibrated and harmonized with therapeutic and natural history implications
-
Ancillary techniques that involve immunocytochemistry, Immunohistochemistry, genetic techniques, grading of STTs, and future investigation
-
Principal aspects in fine needle aspirates and core needle biopsies
Soft Tissue Tumors is the sole reference to offer physicians authoritative guidance in accurate, multidisciplinary investigation and diagnosis in order to make fully informed decisions about the correct course of STT treatment. Clinical and anatomic pathologists, cytopathologists, surgical pathologists, oncologic surgeons, radiologists, and radiation oncologists will rely on this text, as will residents in all pathology, oncology, and radiology subspecialties, cancer epidemiologists, and medical students.
